M. Carolina Danovaro

Dr. M. Carolina Danovaro

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Vaccine
Verified
Journal Article
Open access
HSHeather M. Scobie
Heather M. Scobie
MEMichael Edelstein
Michael Edelstein
ENEdward Nicol
Edward Nicol
AMAna Morice
Ana Morice
NRNargis Rahimi
Nargis Rahimi
JJJaleela Jawad
Jaleela Jawad
• Reported to SAGE on immunization and surveillance data quality & use, October 2019. • Improvements since 2011, but gaps persist in data quality (fit-for-purpose) and use. • Improving data quality and use requires better governance, people, tools, and processes. • Better use of existing data needed to continuously improve programme performance. • Report relevant for “data-guided” implementation of the Immunization Agenda 2030.

31 October 2024 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Open access
CJCamille E. Jones
Camille E. Jones
M. Carolina DanovaroM. Carolina Danovaro
M. Carolina Danovaro
GMGeorge Mwinnyaa
George Mwinnyaa
MGMarta Gacic-Dobo
Marta Gacic-Dobo
LFLauren Francis
Lauren Francis
CSCiara Sugerman
Ciara Sugerman
This report provides an update on global immunization coverage.

24 September 2009 in BMC Public Health
Verified
Journal Article
Open access
PDF file
ARAlba María Ropero-Álvarez
Alba María Ropero-Álvarez
HKHannah J Kurtis
Hannah J Kurtis
M. Carolina DanovaroM. Carolina Danovaro
M. Carolina Danovaro
CRCuauhtémoc Ruiz-Matus
Cuauhtémoc Ruiz-Matus
JAJon K Andrus
Jon K Andrus
Seasonal influenza is a viral disease whose annual epidemics are estimated to cause three to five million cases of severe illness and 250,000 to 500,000 deaths worldwide. Vaccination is the main strategy for primary prevention.

6 April 2022 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
LHLee Lee Ho
Lee Lee Ho
SGSantosh Gurung
Santosh Gurung
IMImran Mirza
Imran Mirza
HNHemanthi Dassanayake Nicolas
Hemanthi Dassanayake Nicolas
CSClaudia Steulet
Claudia Steulet
KKKatrina Kretsinger
Katrina Kretsinger
The COVID-19 pandemic has contributed to the widespread disruption of immunization services, including the postponement of mass vaccination campaigns. In May 2020, the World Health Organization and partners started monitoring COVID-19-related disruptions to mass vaccination campaigns against cholera, measles, meningitis A, polio, tetanus-diphtheria, typhoid, and yellow fever through the Immunization Repository Campaign Delay Tracker. The authors reviewed the number and target population of reported preventive and outbreak response vaccination campaigns scheduled, postponed, canceled, and reinstated at 4 time points: May 2020, December 2020, May 2021, and December 2021. Mass vaccination campaigns across all vaccines were disrupted heavily by COVID-19. In May 2020, 105 of 183 (57%) campaigns were postponed or canceled in 57 countries because of COVID-19, with an estimated 796 million postponed or missed vaccine doses. Campaign resumption was observed beginning in July 2020. In December 2021, 77 of 472 (16%) campaigns in 54 countries, mainly in the African Region, were still postponed or canceled because of COVID-19, with about 382 million postponed or missed vaccine doses. There is likely a high risk of vaccine-preventable disease outbreaks across all regions because of an increased number of susceptible persons resulting from the large-scale mass vaccination campaign postponement caused by COVID-19.

1 August 2018 in Vaccine
Verified
Journal Article
Open access
M. Carolina DanovaroM. Carolina Danovaro
M. Carolina Danovaro
EDEmily Dansereau
Emily Dansereau
DRDale Rhoda
Dale Rhoda
DBDavid W. Brown
David W. Brown
FCFelicity T. Cutts
Felicity T. Cutts
MGMarta Gacic-Dobo
Marta Gacic-Dobo
Household surveys are frequently used as means of vaccination coverage measurement, but obtaining accurate survey estimates present several challenges. In 2015, the World Health Organization (WHO) released a working draft of its updated Vaccination Coverage Survey Reference Manual that moved well beyond the traditional Expanded Program on Immunization (EPI) survey design. In April 2017, WHO convened a four-day meeting, to review lessons learned using the updated manual and to define an agenda for operational research about vaccination coverage surveys. About 70 stakeholders, including EPI managers and participants from 10 countries that have used the updated Survey Manual, survey experts, statisticians, partners, representatives from WHO regional offices and headquarters, and providers of technical assistance discussed methodological issues from sampling to accurately ascertaining a person's vaccination status, optimizing data collection and data management and conducting appropriate analyses. Participants also discussed data sharing and how to best survey data for immunization decision-making. The lessons learned from the use of the updated WHO Survey Manual related mainly to operational issues to implement better quality vaccination coverage surveys. It resulted in a list of 23 recommendations for WHO, donors and partners, immunization programs, and household surveys that collect immunization data. Similarly, 14 research topics, categorized in six themes (overall survey conduction, sampling, vaccination ascertainment, data collection, data analysis and use, and inclusion of questions on knowledge, attitudes and practices) were prioritized. Top areas of further work included improving our understanding of the accuracy of caregiver recall when documented evidence of vaccination is not available, improving engagement and coordination between immunization programs and entities conducting multi-purpose household surveys such as Demographic and Health Survey and Multiple Cluster Indicator Survey, improving mechanisms for sharing vaccination survey datasets and documentation, and making better use of survey results to translate data into knowledge for decision-making. This manuscript summarizes the meeting proceedings and provides an update of actions taken by WHO since this meeting.

21 March 2019 in Gates Open Research
Verified
Journal Article
Open access
PDF file
EDEmily Dansereau
Emily Dansereau
DBDavid Brown
David Brown
LSLena Stashko
Lena Stashko
M. Carolina DanovaroM. Carolina Danovaro
M. Carolina Danovaro
Background: Household survey data are frequently used to estimate vaccination coverage - a key indicator for monitoring and guiding immunization programs - in low and middle-income countries. Surveys typically rely on documented evidence from home-based records (HBR) and/or maternal recall to determine a child’s vaccination history, and may also include health facility sources, BCG scars, and/or serological data. However, there is no gold standard source for vaccination history and the accuracy of existing sources has been called into question. Methods and Findings: We conducted a systematic review of peer-reviewed literature published January 1, 1957 through December 11, 2017 that compared vaccination status at the child-level from at least two sources of vaccination history. 27 articles met inclusion criteria. The percentage point difference in coverage estimates varied substantially when comparing caregiver recall to HBRs (median: +1, range: -43 to +17), to health facility records (median: +5, range: -29 to +34) and to serology (median: -20, range: -32 to +2). Ranges were also wide comparing HBRs to facility-based records (median: +17, range: -61 to +21) and to serology (median: +2, range: -38 to +36). Across 10 studies comparing recall to HBRs, Kappa values exceeded 0.60 in 45% of comparisons; across 7 studies comparing recall to facility-based records, Kappa never reached 0.60. Agreement varied depending on study setting, coverage level, antigen type, number of doses, and child age. Conclusions: Recall and HBR provide relatively concordant vaccination histories in some settings, but both have poor agreement with facility-based records and serology. Long-term, improving clinical decision making and vaccination coverage estimates will depend on strengthening administrative systems and record keeping practices. Short-term, there must be greater recognition of imperfections across available vaccination history sources and explicit clarity regarding survey goals and the level of precision, potential biases, and associated resources needed to achieve these goals.